FOMAT

HyperCORE International

FOMAT Medical Research Joint Venture Partnership with HyperCORE

HyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies.  The members and their companies have over 100 years of combined experience in the Clinical Trial space. Combined, they have completed more than 6,000 studies,…

Read More
Randomized Clinical Trials

Types of Clinical Trials

Clinical Trials, phases I-IV, and types of Randomized Trials. Clinical trials are research studies performed in people that are aimed at evaluating a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment, like…

Read More
Good Clinical Practice

Good Clinical Practice

Abstract Good Clinical Practice (GCP) is an international ethical and scientific quality standard for the design, conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials. It also serves to protect the rights, integrity, and confidentiality of trial subjects. It…

Read More
TOP CROs

Top Clinical Research Organizations at a Glance!

Clinical Research would be a lot more difficult without the help of Clinical Research Organizations (CROs). These companies within the pharmaceutical industry not only help support drug companies but also companies in the biotechnology and medical device industries as well. Some…

Read More
doctor-preparing-medical-vaccine

A phase 3 study for chikungunya vaccine after passing midstage test

The chikungunya vaccine, known as MV-CHIK, hit its primary goal in the phase 2 trial, and Themis is now eyeing a move into phase 3. The company based its chikungunya shot on its measles vector platform, licensed from Institut Pasteur. In the…

Read More
Heart disease prevention

A new way to prevent heart disease in Type 1 diabetes

Scientists reveal the mechanism which allows a commonly prescribed drug for Type 2 diabetes to prevent heart disease in patients with Type 1 diabetes and could lead to new treatments. Metformin is an inexpensive treatment that is often used for Type…

Read More
Launch Website 2018

FOMAT Announces New Website Launch

A new design to improve the experience of our visitors. CALIFORNIA (Oct. 12th, 2018) — FOMAT Medical Research launches their newly redesigned website that offers a new experience to our visitors. The new website will allow visitors to learn more about…

Read More
World cancer day (February 4). Woman hand holding Lavender purpl

Lupus Treatment Generates Positive Results in Phase III Clinical Trial

New research indicates that belimumab, a monoclonal antibody therapy that targets a component of the immune system, provides considerable benefits to patients with systemic lupus erythematosus (SLE), a predominately female, chronic inflammatory disease that can affect virtually any organ. The Arthritis &…

Read More
Tumor immunity

Personalized Tumor Vaccine Shows Promise in Pilot Trial

A new type of cancer vaccine harnesses tumor immunity has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and the Abramson Cancer Center of the University of Pennsylvania. The…

Read More
NF_Forbes

Forbes Nominates Nicholas Focil As Part Of The LA Business Council

[Los Angeles, CA. March 7, 2018] — [Fomat Medical Research CEO Nicholas Focil], [Clinical Research Network in the US and LatAm], has been accepted into the Forbes Los Angeles Business Council, the foremost growth and networking organization for small businesses in Greater…

Read More